Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule 2 promoter

Transplantation

Volumn 62, Issue 2, 1996, Pages 155-160

  Cowan, Peter J ^a   Shinkel, Trixie A ^a   Witort, Ewa J ^a   Barlow, Helen ^a   Pearse, Martin J ^a   D'Apice, Anthony J F ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 2;

ANIMAL CELL; ARTICLE; CELL ADHESION; DNA FLANKING REGION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ENGINEERING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD; BASE SEQUENCE; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SENSITIVITY AND SPECIFICITY;

EID: 0029982713     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607270-00002     Document Type: Article

References (27)

1. Bach FH, Robson SC, Winkler H, et al. Barriers to xenotransplantation. Nature Med 1995; 1: 869.
2. White DJG, Langford GA, Cozzi E, Young VK. Production of pigs transgenic for human DAF: a strategy for xenotransplantation. Xenotransplantation 1995; 2: 213.
3. Fodor WL, Williams BL, Matis LA, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91: 11153.
4. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med 1995; 1: 1261.
5. Chen C-G, Fisicaro N, Shinkel TA, et al. Reduction in Gal-α1,3-Gal epitope expression in transgenic mice expressing human H-transferase. Xenotransplantation (in press).
6. Aird WC, Jahroudi N, Weiler-Guettler H, Rayburn HB, Rosenberg RD. Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci USA 1995; 92: 4567.
7. Schlaeger TM, Qin Y, Fujiwara Y, Magram J, Sato TN. Vascular endothelial cell lineage-specific promoter in transgenic mice. Development 1995; 121: 1089.
8. Jahroudi N, Lynch DC. Endothelial-cell-specific regulation of von Willebrand factor gene expression. Mol Cell Biol 1994; 14: 999.
9. Harats D, Kurihara H, Belloni P, et al. Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter. J Clin Invest 1995; 95: 1335.
10. Pan JL, McEver RP. Characterization of the promoter for the human P-selectin gene. J Biol Chem 1993; 268: 22600.
11. Zhang R, Min W, Sessa WC. Functional analysis of the human endothelial nitric oxide synthase promoter - SP1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem 1995; 270: 15320.
12. de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991; 174: 253.
13. Risau W. Differentiation of endothelium. FASEB J 1995; 9: 926.
14. Diacovo TG, de Fougerolles AR, Bainton DF, Springer TA. A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2. J Clin Invest 1994; 94: 1243.
15. Choi T, Huang M, Gorman C, Jaenisch R. A generic intron increases gene expression in transgenic mice. Mol Cell Biol 1991; 11: 3070.
16. Somerville CA, Kyriazis AG, McKenzie A, Allison J, Pearse MJ, d'Apice AJF. Functional expression of human CD59 in transgenic mice. Transplantation 1994; 58: 1430.
17. Reddy VB, Ghosh PK, Lebowitz P, Weissman SM. Gaps and duplicated sequences in the leaders of SV40 16S RNA. Nucleic Acids Res 1978; 5: 4195.
18. Panaccio M, Georgesz M, Lew AM. FoLT PCR: a simple PCR protocol for amplifying DNA directly from whole blood. Bio-Techniques 1993; 14: 238.
19. Holmes KL, Langdon WY, Fredrickson TN, et al. Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts. J Immunol 1986; 137: 679.
20. Xu H, Tong IL, de Fougerolles AR, Springer TA. Isolation, characterization, and expression of mouse ICAM-2 complementary and genomic DNA. J Immunol 1992; 149: 2650.
21. McEver RP. Selectins: novel receptors that mediate leukocyte adhesion during inflammation. Thromb Haemost 1991; 66: 223.
22. Sadler JE. von Willebrand factor. J Biol Chem 1991; 266: 22777.
23. Connelly S, Manley JL. RNA polymerase II transcription termination is mediated specifically by protein binding to a CCAAT box sequence. Mol Cell Biol 1989; 9: 5254.
24. Graves BJ, Johnson PF, McKnight SL. Homologous recognition of a promoter domain common to the MSV LTR and HSV tk gene. Cell 1986; 44: 565.
25. Evans RR, Calmels TP, Pitt BR, et al. Gene therapy and endothelial cell targeting for cancer. Ann N Y Acad Sci 1994; 716: 257.
26. Furth PA, Stonge L, Boger H, et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994; 91: 9302.
27. Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1989; 339: 61.